Winton Group’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-18,929
| Closed | -$116K | – | 934 |
|
|
2023
Q1 | $116K | Buy |
18,929
+208
| +1% | +$1.27K | 0.01% | 926 |
|
|
2022
Q4 | $120K | Buy |
18,721
+879
| +5% | +$5.62K | 0.01% | 882 |
|
|
2022
Q3 | $171K | Buy |
+17,842
| New | +$171K | 0.01% | 884 |
|
|
2022
Q2 | – | Sell |
-16,190
| Closed | -$270K | – | 1008 |
|
|
2022
Q1 | $270K | Buy |
16,190
+3,089
| +24% | +$51.5K | 0.01% | 842 |
|
|
2021
Q4 | $250K | Buy |
+13,101
| New | +$250K | 0.02% | 885 |
|
|
2021
Q1 | – | Sell |
-15,264
| Closed | -$708K | – | 1409 |
|
|
2020
Q4 | $708K | Sell |
15,264
-3,101
| -17% | -$144K | 0.05% | 603 |
|
|
2020
Q3 | $605K | Buy |
+18,365
| New | +$605K | 0.02% | 1032 |
|